These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 1396988
1. Effects of imidazoline-related compounds on the mechanical response to nicorandil in the rat portal vein. Okumura K, Ichihara K, Nagasaka M. Eur J Pharmacol; 1992 May 14; 215(2-3):253-7. PubMed ID: 1396988 [Abstract] [Full Text] [Related]
2. Potassium channel opening properties of a novel compound, NIP-121, cromakalim and nicorandil in rat aorta and portal vein. Masuda Y, Arakawa C, Yamashita T, Miyajima M, Shigenobu K, Kasuya Y, Tanaka S. Eur J Pharmacol; 1991 Apr 03; 195(3):323-31. PubMed ID: 1831135 [Abstract] [Full Text] [Related]
3. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery. Fujiwara T, Angus JA. Br J Pharmacol; 1996 Dec 03; 119(8):1549-56. PubMed ID: 8982500 [Abstract] [Full Text] [Related]
7. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil. Yanagisawa T, Teshigawara T, Taira N. Br J Pharmacol; 1990 Sep 03; 101(1):157-65. PubMed ID: 2149290 [Abstract] [Full Text] [Related]
8. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system. Cavero I, Pratz J, Mondot S. Z Kardiol; 1991 Sep 03; 80 Suppl 7():35-41. PubMed ID: 1838848 [Abstract] [Full Text] [Related]
9. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model]. Kamijo T, Tomaru T, Miwa A, Nakamura F, Kido H, Sugimoto T, Uchida Y. Nihon Yakurigaku Zasshi; 1992 Oct 03; 100(4):317-27. PubMed ID: 1446882 [Abstract] [Full Text] [Related]
10. Nicorandil as a nitrate, and cromakalim as a potassium channel opener, dilate isolated porcine large coronary arteries in an agonist-nonselective manner. Satoh K, Mori T, Yamada H, Taira N. Cardiovasc Drugs Ther; 1993 Aug 03; 7(4):691-9. PubMed ID: 8241013 [Abstract] [Full Text] [Related]
11. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs. Zografos P, Li JH, Kau ST. Pharmacology; 1992 Aug 03; 45(4):216-30. PubMed ID: 1438528 [Abstract] [Full Text] [Related]
12. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery. Zhou Q, Satake N, Shibata S. Eur J Pharmacol; 1995 Jan 24; 273(1-2):153-9. PubMed ID: 7737309 [Abstract] [Full Text] [Related]
13. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. McPherson GA, Angus JA. Br J Pharmacol; 1990 Jun 24; 100(2):201-6. PubMed ID: 2116201 [Abstract] [Full Text] [Related]
15. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle. Satoh E, Yanagisawa T, Taira N. Jpn J Pharmacol; 1990 Oct 24; 54(2):133-41. PubMed ID: 2150209 [Abstract] [Full Text] [Related]
17. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta. Uchida W, Hirano Y, Shirai Y, Taguchi T, Masuda N, Shibasaki K, Hirano S, Matsumoto Y, Tsuzuki R, Yanagisawa I. Arch Int Pharmacodyn Ther; 1994 Oct 24; 327(3):330-43. PubMed ID: 7848015 [Abstract] [Full Text] [Related]
18. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim. Zhang H, Stockbridge N, Weir B, Vollrath B, Cook D. Gen Pharmacol; 1992 Mar 24; 23(2):197-201. PubMed ID: 1353469 [Abstract] [Full Text] [Related]
19. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Weir SW, Weston AH. Br J Pharmacol; 1986 May 24; 88(1):121-8. PubMed ID: 2423172 [Abstract] [Full Text] [Related]
20. The effect of some alpha-adrenoceptor antagonists on spontaneous myogenic activity in the rat portal vein and the putative involvement of ATP-sensitive K+ channels. Schwietert R, Wilhelm D, Wilffert B, Van Zwieten PA. Eur J Pharmacol; 1992 Jan 28; 211(1):87-95. PubMed ID: 1352250 [Abstract] [Full Text] [Related] Page: [Next] [New Search]